Reviews of glyphosate show no cancerous risk

Monsanto retained Interteck Scientific and Regulatory Consultancy this year to review the International Agency for Research on Cancer’s (IARC) monograph on glyphosate.

A panel of experts presented its findings during the Society for Risk Assessment annual meeting.

The panel of experts decided that glyphosate does not show evidence of a potential human carcinogenesis. The IARC animal bioassay and genotoxicity evaluations suffered from a multitude of problems.

The panel said the evaluations “suffered from significant weaknesses such as: selectivity in the choice of data reviewed, failure to use all relevant biologic information to evaluate relationship to treatment in animal bioassays, and failure to use weight-of-evidence evaluations using all available data and appropriate weighting.”

A conclusion by the European Food Safety Authority agreed that “glyphosate is unlikely to pose a carcinogenic hazard to humans." The Canadian Pest Management Regulatory Agency said in April, “the overall weight of evidence indicates that glyphosate is unlikely to pose a human cancer risk.” Finally, the Environmental Protection Agency said that 55 epidemiological studies found there is no evidence to show glyphosate causes cancer.

Organizations in this Story

Monsanto Company U.S. Environmental Protection Agency (EPA)

Want to get notified whenever we write about any of these organizations ?
Next time we write about any of these organizations, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.